DXC Technology Projects Organic Revenue Decline for FY2027 and Explores Insurance Business Sale
DXC Technology (NYSE: DXC) has issued a cautious outlook for fiscal year 2027, projecting an organic revenue decline between 5% and 5.5%. This guidance comes as the company undergoes strategic evaluations to optimize its business portfolio and enhance shareholder value. During the Q2 FY2027 earnings call, management confirmed that they are in ongoing discussions regarding a potential sale of the company's insurance business unit. The Board of Directors is actively exploring various strategic actions and divestiture options to stabilize performance and improve long-term financial outcomes.
Tickers: $DXC
Topics: potential sale of insurance business shareholder value strategic alternatives